|
ATE310566T1
(de)
*
|
1998-09-18 |
2005-12-15 |
Alcon Mfg Ltd |
5ht2-agoniste zur behandlung des glaukoms
|
|
AU2183900A
(en)
|
1998-12-24 |
2000-07-31 |
Alcon Laboratories, Inc. |
Ep4 receptor agonists for treatment of dry eye
|
|
US6462080B1
(en)
|
1998-12-24 |
2002-10-08 |
Alcon Manufacturing, Ltd. |
Prostaglandin E receptor agonists for treatment of dry eye
|
|
TWI225398B
(en)
*
|
1999-07-14 |
2004-12-21 |
R Tech Ueno Ltd |
Composition for treatment of external secretion disorders
|
|
WO2001034553A2
(en)
*
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use
|
|
PT1228030E
(pt)
|
1999-11-09 |
2005-08-31 |
Alcon Inc |
Derivados benzenoidicos do acido 15-hidroxieicosatetraenoico e metodos para a sua utilizacao no tratamento das perturbacoes do olho seco
|
|
HK1045985B
(en)
|
1999-11-09 |
2004-04-23 |
Alcon, Inc. |
15-hydroxyeicosatetraenoic acid-related compounds and methods of use
|
|
PT1228028E
(pt)
*
|
1999-11-09 |
2005-10-31 |
Alcon Inc |
Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
|
|
WO2001034550A2
(en)
|
1999-11-09 |
2001-05-17 |
Alcon Universal Ltd. |
15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders
|
|
DK1228027T3
(da)
*
|
1999-11-09 |
2004-07-19 |
Alcon Inc |
3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse
|
|
DE60019322T2
(de)
|
1999-11-09 |
2005-09-08 |
Alcon Inc. |
Heteroatomunterbrochene analoge von15-hydroxyeicosatetraensäure und verfahren zu deren verwendung
|
|
US6803385B2
(en)
|
1999-11-09 |
2004-10-12 |
Alcon, Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
|
AU1226001A
(en)
|
1999-11-09 |
2001-06-06 |
Alcon Universal Limited |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
|
|
US6552084B2
(en)
|
1999-11-09 |
2003-04-22 |
Alcon Universal Ltd. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
|
CA2386632A1
(en)
|
1999-11-09 |
2001-05-17 |
Alcon, Inc. |
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
|
|
US6458854B2
(en)
|
1999-11-09 |
2002-10-01 |
Alcon Universal Ltd. |
Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use
|
|
PT1228032E
(pt)
*
|
1999-11-09 |
2004-10-29 |
Alcon Inc |
Composicoes contendo derivados do acido hidroxieicosatetraenoico e metodos de utilizacao para o tratamento de desordens do olho seco
|
|
DK1418167T3
(da)
*
|
1999-11-09 |
2005-04-25 |
Alcon Inc |
Hydroxyicosatetraensyreanaloger og fremgangsmåder til deres anvendelse til behandling af öjentörhedslidelser
|
|
ATE258791T1
(de)
*
|
1999-11-09 |
2004-02-15 |
Alcon Inc |
Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
|
|
AU776254B2
(en)
*
|
1999-11-09 |
2004-09-02 |
Alcon Inc. |
Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders
|
|
AU2603301A
(en)
|
1999-12-22 |
2001-07-03 |
Alcon Universal Limited |
6-keto prostaglandin F1alpha and analogs for treating dry eye
|
|
US6277855B1
(en)
*
|
2000-04-21 |
2001-08-21 |
Inspire Pharmaceuticals, Inc. |
Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
|
|
AU2002224337A1
(en)
*
|
2000-10-23 |
2002-05-06 |
Alcon, Inc. |
Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
|
|
DK1330246T3
(da)
|
2000-10-23 |
2005-08-08 |
Alcon Inc |
Anvendelse af hydroxyicosatetraensyrederivater ved intraokulær kirurgi
|
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
|
JP2004527578A
(ja)
|
2001-05-21 |
2004-09-09 |
アルコン，インコーポレイテッド |
ドライアイ障害を処置するためのＮＦ−κＢインヒビターの使用
|
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
|
BR0209883A
(pt)
|
2001-05-21 |
2004-06-08 |
Alcon Inc |
Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco
|
|
US7112588B2
(en)
*
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
|
EP1392322A1
(en)
*
|
2001-05-21 |
2004-03-03 |
Alcon, Inc. |
Method of treating dry eye disorders
|
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
|
US6750250B1
(en)
|
2001-07-12 |
2004-06-15 |
Alcon, Inc. |
11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
|
|
WO2003030892A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
|
PL369960A1
(en)
*
|
2001-10-11 |
2005-05-02 |
Alcon, Inc. |
Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
|
|
WO2003030894A1
(en)
*
|
2001-10-11 |
2003-04-17 |
Alcon, Inc. |
Methods for treating dry eye
|
|
EP1583527A1
(en)
*
|
2002-06-14 |
2005-10-12 |
Alcon, Inc. |
Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
|
|
AU2003221707A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Alcon, Inc. |
Topical use of hydroxyeicosatetraenoic acid compounds to treat psoriasis
|
|
FR2843026B1
(fr)
*
|
2002-08-02 |
2006-01-06 |
Goemar Lab Sa |
Nouveau medicament
|
|
EP1542768A1
(en)
*
|
2002-09-20 |
2005-06-22 |
Alcon, Inc. |
Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
|
|
US20040248794A1
(en)
*
|
2002-12-20 |
2004-12-09 |
Yanni John M. |
Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
|
|
WO2004093878A1
(en)
|
2003-04-16 |
2004-11-04 |
Alcon, Inc. |
Use of fused pyridazine derivatives for treating dry eye disorders
|
|
US20050202097A1
(en)
*
|
2004-03-12 |
2005-09-15 |
Melbj Holdings, Llc, Florida |
Lubricant for the ocular surface
|
|
US8455016B2
(en)
|
2004-03-12 |
2013-06-04 |
Melbj Holdings, Llc |
Treatment for meibomian gland dysfunction or obstruction
|
|
DE602005017762D1
(de)
*
|
2004-05-14 |
2009-12-31 |
Alcon Inc |
Methode zur behandlung trockener augen und uveitis
|
|
US7923471B2
(en)
*
|
2004-05-14 |
2011-04-12 |
Alcon, Inc. |
Method of treating dry eye disorders and uveitis
|
|
US7223737B1
(en)
|
2004-08-13 |
2007-05-29 |
Alcon, Inc. |
Method of treating dry eye disorders using glycosides
|
|
WO2006022291A1
(ja)
*
|
2004-08-27 |
2006-03-02 |
Senju Pharmaceutical Co, .Ltd. |
ドライアイ治療用点眼液
|
|
US20060128803A1
(en)
*
|
2004-12-14 |
2006-06-15 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(S)-HODE and its analogs
|
|
US7745461B1
(en)
|
2006-02-27 |
2010-06-29 |
Alcon Research, Ltd. |
Method of treating dry eye disorders
|
|
NZ582188A
(en)
*
|
2007-07-11 |
2012-03-30 |
Pfizer |
Pharmaceutical compositions and methods of treating dry eye disorders
|
|
US20090048368A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Bash Thomas F |
Polyolefin compositions comprising bio-based starch materials
|
|
JP5421272B2
(ja)
*
|
2007-10-12 |
2014-02-19 |
リゾルヴィクス・ファーマシューティカルズ・インコーポレイテッド |
眼病治療のための組成物及び方法
|
|
AU2014201375B2
(en)
*
|
2007-10-12 |
2015-11-05 |
Resolvyx Pharmaceuticals, Inc. |
Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions
|
|
US20090098136A1
(en)
*
|
2007-10-15 |
2009-04-16 |
Alcon Research, Ltd. |
Use of tnf receptor antagonists for treating dry eye
|
|
TW200927192A
(en)
*
|
2007-11-19 |
2009-07-01 |
Alcon Res Ltd |
Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
|
|
US8207226B1
(en)
|
2008-06-03 |
2012-06-26 |
Alcon Research, Ltd. |
Use of FAAH antagonists for treating dry eye and ocular pain
|
|
GB0907413D0
(en)
|
2009-04-29 |
2009-06-10 |
Equateq Ltd |
Novel methods
|
|
EP2496233A1
(en)
*
|
2009-11-06 |
2012-09-12 |
Alcon Research, Ltd. |
Nutritional supplements for relief of dry eye
|
|
JP2016538288A
(ja)
*
|
2013-11-15 |
2016-12-08 |
ディグニティ サイエンシス リミテッド |
多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩
|
|
CN109311976A
(zh)
|
2016-06-20 |
2019-02-05 |
诺华股份有限公司 |
使用TNFα拮抗剂治疗干眼症的方法
|
|
US20210315851A1
(en)
|
2020-04-03 |
2021-10-14 |
Afimmune Limited |
Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
|